Analysis of Genomic and Transcriptomic Data Revealed Key Genes and Processes in the Development of Major Depressive...

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• Major depressive disorder (MDD) affects millions globally, with current treatments often failing to achieve sustained remission.
• Insufficient understanding of MDD's underlying causes (etiopathogenesis) limits treatment efficacy.

Purpose of the Study:

• To identify key genes, biological pathways, and master regulatory proteins implicated in MDD.
• To integrate genomic and transcriptomic data for a comprehensive view of MDD mechanisms.

Main Methods:

• Performed a transcriptome-wide association study (TWAS) to link gene transcription levels with MDD risk.
• Conducted pathway enrichment analysis on TWAS results to identify associated biological processes.
• Analyzed transcriptomic data from brain regions to confirm and refine genome-level findings.

Main Results:

• Identified MDD associations beyond neurotransmitter metabolism, including phospholipid and glycan metabolism, chromatin remodeling, RNA processing, and cell-extracellular matrix interactions.
• Confirmed genome-level findings with transcriptomic analysis in brain regions.
• Discovered significant sex-specific gene expression patterns in the brain, with some genes showing opposite transcriptional changes in males and females.
• Identified master regulators (proteins controlling gene transcription) crucial for MDD pathogenesis.

Conclusions:

• MDD involves complex biological pathways beyond traditional neurotransmitter systems.
• Sex-specific gene expression in the brain is a critical factor in MDD.
• Master regulators identified represent potential therapeutic targets for MDD.